Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 8/20 | 0.41 |
| ▸ | MRGPRX4 | Q96LA9 | 4/20 | 0.36 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
| ▸ | RORC | P51449 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7516842 | 1.00 | HIF1A (0.41) | HIF1AMRGPRX4SCN9ATP53HTT | |
| SCHEMBL7522130 | 0.90 | HIF1A (0.43) | HIF1AMRGPRX4SCN9ATP53HTT | |
| SCHEMBL7522128 | 0.90 | HIF1A (0.43) | HIF1AMRGPRX4SCN9ATP53HTT | |
| SCHEMBL8370605 | 0.87 | HIF1A (0.50) | HIF1AMRGPRX4SCN9ALMNASMN1; SMN2 | |
| SCHEMBL8370602 | 0.87 | HIF1A (0.50) | HIF1AMRGPRX4SCN9ALMNASMN1; SMN2 | |
| SCHEMBL829037 | 0.84 | HIF1A (0.49) | HIF1AMRGPRX4SCN9ATP53HTT | |
| SCHEMBL829036 | 0.84 | HIF1A (0.49) | HIF1AMRGPRX4SCN9ATP53HTT | |
| SCHEMBL8343050 | 0.83 | HIF1A (0.46) | HIF1AMRGPRX4SCN9ATP53HTT | |
| SCHEMBL8343054 | 0.83 | HIF1A (0.46) | HIF1AMRGPRX4SCN9ATP53HTT | |
| SCHEMBL7521311 | 0.81 | HIF1A (0.45) | HIF1AMRGPRX4SCN9ATP53HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020035259-A1 | 2-methoxyimino-2-(pyridinyloxymethyl)phenyl acetamides with (derivatised) hydroxyalkyl derivatives on the pyridine ring | CANADA EMILY J (US) | 2002-03-21 | — | — | US | disclosed |
| US-20020035257-A1 | 2-methoxyimino-2-(pyridinyloxymethyl) phenyl acetamides with (derivatised) hydroxyalkyl derivatives on the pyridine ring | CANADA EMILY J (US) | 2002-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020035259-A1 | 2-methoxyimino-2-(pyridinyloxymethyl)phenyl acetamides with (derivatised) hydroxyalkyl derivatives on the pyridine ring | AADAC, CYP1A2, NAAA | HIF1A 4113/4885MRGPRX4 1904/4885SCN9A 2122/4885 |
| US-20020035257-A1 | 2-methoxyimino-2-(pyridinyloxymethyl) phenyl acetamides with (derivatised) hydroxyalkyl derivatives on the pyridine ring | AADAC, CYP1A2, NAAA | HIF1A 4113/4885MRGPRX4 1904/4885SCN9A 2122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.